IL88564A - תכשירי רוקחות למניעת הדבקות של אברים אול חלקי אברים - Google Patents

תכשירי רוקחות למניעת הדבקות של אברים אול חלקי אברים

Info

Publication number
IL88564A
IL88564A IL8856488A IL8856488A IL88564A IL 88564 A IL88564 A IL 88564A IL 8856488 A IL8856488 A IL 8856488A IL 8856488 A IL8856488 A IL 8856488A IL 88564 A IL88564 A IL 88564A
Authority
IL
Israel
Prior art keywords
organs
pharmaceutical composition
adhesions
parts
disease
Prior art date
Application number
IL8856488A
Other languages
English (en)
Other versions
IL88564A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL88564A0 publication Critical patent/IL88564A0/xx
Publication of IL88564A publication Critical patent/IL88564A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL8856488A 1987-12-04 1988-12-02 תכשירי רוקחות למניעת הדבקות של אברים אול חלקי אברים IL88564A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873741149 DE3741149A1 (de) 1987-12-04 1987-12-04 Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen

Publications (2)

Publication Number Publication Date
IL88564A0 IL88564A0 (en) 1989-07-31
IL88564A true IL88564A (he) 1994-12-29

Family

ID=6341894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8856488A IL88564A (he) 1987-12-04 1988-12-02 תכשירי רוקחות למניעת הדבקות של אברים אול חלקי אברים

Country Status (18)

Country Link
US (1) US5578305A (he)
EP (1) EP0318801B1 (he)
JP (1) JP2741767B2 (he)
KR (1) KR970010545B1 (he)
AT (1) ATE67678T1 (he)
AU (1) AU622632B2 (he)
CA (1) CA1330298C (he)
DE (2) DE3741149A1 (he)
DK (1) DK167049B1 (he)
ES (1) ES2037803T3 (he)
GR (1) GR3003156T3 (he)
HK (1) HK181596A (he)
HU (1) HU201476B (he)
IE (1) IE61464B1 (he)
IL (1) IL88564A (he)
NZ (1) NZ227183A (he)
PH (1) PH31058A (he)
ZA (1) ZA889048B (he)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462829B (sv) * 1989-01-10 1990-09-10 Kabigen Ab Trombolytiskt aktiva kompositioner innehaallande en modifierad plasminogenaktivator av vaevnadstyp samt en normal human t-pa, streptokinas eller humant urokinas
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
EP0887076A3 (en) * 1997-05-07 1999-03-31 Saturnus A.G. Adhesion prevention and an endoscopic insufflation system therefor
EP1556121B1 (en) 2002-10-28 2016-06-01 Northgate Technologies Incorporated Insufflation system with a multi-capacity tube
US7654975B2 (en) * 2003-04-24 2010-02-02 Northgate Technologies, Inc. Mixed-gas insufflation system
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
ES2336796T3 (es) * 2003-10-07 2010-04-16 Northgate Technologies Incorporated Sistema para suministrar una sustancia a una cavitacion corporal.
US7914517B2 (en) 2003-10-31 2011-03-29 Trudell Medical International System and method for manipulating a catheter for delivering a substance to a body cavity
CA2623471C (en) * 2004-09-23 2018-02-13 Arc Pharmaceuticals, Inc. Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
US8663271B2 (en) 2006-08-04 2014-03-04 Northgate Technologies, Inc. In-dwelling port for access into a body
US9572595B1 (en) 2014-03-05 2017-02-21 Northgate Technologies Inc. In-dwelling port for access into a body
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
US4604384A (en) * 1982-06-24 1986-08-05 Smith Robert A Pharmaceutical gel composition
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
KR870005646A (ko) * 1985-12-16 1987-07-06 로버트 엘. 미니어 수술후 유착형성 억제방법
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
EP0297860B1 (en) * 1987-07-01 1993-09-01 Genentech, Inc. Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
SE8900586L (sv) * 1989-02-21 1990-08-22 Pharmacia Ab Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader

Also Published As

Publication number Publication date
EP0318801B1 (de) 1991-09-25
HUT49289A (en) 1989-09-28
IL88564A0 (en) 1989-07-31
PH31058A (en) 1998-02-05
DE3865182D1 (he) 1991-10-31
HU201476B (en) 1990-11-28
EP0318801A2 (de) 1989-06-07
DK672488D0 (da) 1988-12-02
EP0318801A3 (en) 1989-08-09
JPH01193230A (ja) 1989-08-03
IE61464B1 (en) 1994-11-02
JP2741767B2 (ja) 1998-04-22
AU622632B2 (en) 1992-04-16
ZA889048B (en) 1990-08-29
IE883608L (en) 1989-06-04
KR970010545B1 (ko) 1997-06-28
KR890009408A (ko) 1989-08-01
DK672488A (da) 1989-06-05
CA1330298C (en) 1994-06-21
ES2037803T3 (es) 1993-07-01
DK167049B1 (da) 1993-08-23
NZ227183A (en) 1991-07-26
US5578305A (en) 1996-11-26
DE3741149A1 (de) 1989-06-15
AU2648588A (en) 1989-06-08
ATE67678T1 (de) 1991-10-15
HK181596A (en) 1996-10-04
GR3003156T3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
US5364622A (en) Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
US4889722A (en) Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
JP2006193535A (ja) フィブリン溶解増強剤の局所送達
US20060148698A1 (en) Storage-stable fibrinogen solutions
CA1330298C (en) Preparations for preventing adhesions of organs and parts of organs
JP2690944B2 (ja) 組織プラスミノーゲンアクチベーター活性を有するタンパク質の高濃度溶液
EP0297860B1 (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
EP0438234B1 (en) Antithrombin solution and use thereof
ES2399138T3 (es) Tratamiento local con factor VII
JPH08253425A (ja) 傷治癒を改善するプラスミノーゲン活性化因子からなる製剤の使用
KR20040055782A (ko) 보관-안정한 인간 피브리노겐 용액
US5589169A (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
EP2852401A1 (en) Methods and compositions for reducing the incidence of post-surgical adhesions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired